Thermo Fisher Scientific TMO Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | 13.5%+0.5pp | 13%-0.1pp | 13.1%-0.3pp | 13.4%-0.3pp | 13.7%+0.6pp | |
| Return on assets | 6.5%0.0pp | 6.5%0.0pp | 6.5%-0.1pp | 6.6%-0.1pp | 6.6%+0.2pp | |
| Liquidity | ||||||
| Current ratio | 1.5×-0.4× | 1.9×+0.4× | 1.5×-0.4× | 1.9×+0.2× | 1.8×+0.1× | |
| Quick ratio | 1.2×-0.4× | 1.5×+0.4× | 1.1×-0.4× | 1.5×+0.1× | 1.4×+0.1× | |
| Cash ratio | 0.2×-0.4× | 0.7×+0.5× | 0.1×-0.2× | 0.4×0.0× | 0.3×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×0.0× | 0.8×+0.1× | 0.8×0.0× | 0.7×0.0× | 0.7×0.0× | |
| Debt-to-assets | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Per Share | ||||||
| Book value per share | $139.23-1.5% | $141.29+4.7% | $134.97+1.0% | $133.63+2.5% | $130.32+0.7% | |
| Valuation | ||||||
| Market capitalization | $182.6B-16.1% | $217.7B+18.9% | $183.15B+20.0% | $152.65B-18.7% | $187.73B-5.7% | |
| Enterprise value | $222.48B-11.8% | $252.21B+14.3% | $220.64B+19.0% | $185.49B-15.9% | $220.56B-4.1% | |
| Price / earnings | 26.7×-5.8× | 32.5×+4.6× | 27.9×+4.7× | 23.2×-5.6× | 28.8×-2.6× | |
| Price / book | 3.5×-0.6× | 4.1×+0.5× | 3.6×+0.6× | 3×-0.8× | 3.8×-0.2× | |
| Free cash flow yield | 3.7%+0.8pp | 2.9%-0.4pp | 3.3%-0.7pp | 4%+0.5pp | 3.6%-0.1pp | |
| Earnings yield | 3.8%+0.7pp | 3.1%-0.5pp | 3.6%-0.7pp | 4.3%+0.8pp | 3.5%+0.3pp | |
| Dividend yield | 0.4%+0.1pp | 0.3%0.0pp | 0.3%-0.1pp | 0.4%+0.1pp | 0.3%0.0pp | |
| PEG ratio | 5.2×-0.4× | 5.6×+1.5× | 4.1×+0.2× | 4×+0.3× | 3.6×-1.9× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Thermo Fisher Scientific's profit margins?
- Thermo Fisher Scientific (TMO) runs a 58.3% gross margin and a 17.2% operating margin, with a 15.2% net margin.
- Where do Thermo Fisher Scientific's ratios come from?
- Every ratio is computed from Thermo Fisher Scientific's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
